Below is a listing of treatments and therapies for psoriasis and psoriatic arthritis. Click on one to read more information or connect with others currently using it.
Abrilada (adalimumab-afzb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis.
Acthar Gel (repository corticotropin injection) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for short-term use with other treatment during a flare of…
read moreAmjevita (adalimumab-atto) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis.
Avsola (infliximab-axxq) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic severe plaque psoriasis.
Bimzelx (bimekizumab-bkzx) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in…
read moreOverview
Calcitrene is approved by the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis in adults. It is prescribed for individuals with mild to moderate plaque psoriasis and should not be…
Cimzia (certolizumab pegol) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque…
read moreCosentyx (secukinumab) is a biologic medicine approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in…
read moreCyltezo (adalimumab-adbm) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreDovonex (calcipotriene) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis.
These insights are…
Duobrii (halobetasol propionate and tazarotene) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with plaque psoriasis.
Enbrel (etanercept) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults…
read moreOverview
Erelzi is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat psoriatic arthritis and moderate to severe chronic plaque psoriasis in adults. Erelzi may be referred to by… read more
Eticovo (etanercept-ykro) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children 4 years and older with moderate to severe plaque psoriasis or…
read moreHadlima (adalimumab-bwwd) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreHulio (adalimumab-fkjp) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis or active…
read moreHumira (adalimumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults.
… read moreHyrimoz (adalimumab-adaz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreIcotyde (icotrokinra) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 12 and older with moderate to severe plaque psoriasis…
read moreIdacio (adalimumab-aacf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreIlumya (tildrakizumab-asmn) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque…
read moreImuldosa (ustekinumab-srlf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 6 and older with moderate to severe plaque…
read moreInflectra (infliximab-dyyb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic severe plaque psoriasis.
Ixifi (infliximab-qbtx) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic severe plaque psoriasis.
The drug maintains its official FDA…
read moreBecome a member to get even more